Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nutritional and metabolic endpoints

M W Haymond1

  • 1Baylor College of Medicine, Children's Nutrition Research Center/Agricultural Research Service, Houston, Texas 77030, USA.

The Journal of Nutrition
|January 23, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Racial and ethnic differences among children with new-onset autoimmune Type 1 diabetes.

Diabetic medicine : a journal of the British Diabetic Association·2017
Same author

Morbidly obese paediatric patients are not adequately screened for comorbidities.

Clinical obesity·2015
Same author

Serum adiposity-induced biomarkers in obese and lean children with recently diagnosed autoimmune type 1 diabetes.

Pediatric diabetes·2014
Same author

Glucose production, gluconeogenesis, and insulin sensitivity in children and adolescents: an evaluation of their reproducibility.

Pediatric research·2001
Same author

Mini-dose glucagon rescue for hypoglycemia in children with type 1 diabetes.

Diabetes care·2001
Same author

We are carried high and raised up by their giant size.

Diabetes, nutrition & metabolism·2000
Same journal

Microbial-derived polyphenol metabolites and the gut microbiota: A scoping review of clinical studies.

The Journal of nutrition·2026
Same journal

Hesperidin as an Emerging Nutraceutical in Modern Health and Preventive Medicine: A Narrative Review.

The Journal of nutrition·2026
Same journal

Short-Chain Fatty Acids in Livestock and Aquatic Animals: Metabolic Divergence, Physiological Functions, and Product Development.

The Journal of nutrition·2026
Same journal

Immunomodulatory properties of choline and its dietary forms throughout the lifespan.

The Journal of nutrition·2026
Same journal

Oat-rich low-gluten diet modulates plasma short-chain fatty acids without significant changes in fecal microbiome or inflammatory markers - a randomized clinical trial in people with cardiometabolic risk.

The Journal of nutrition·2026
Same journal

Diet and Cognitive Function in Aging: An Individual Participant Data Meta-Analysis from Eight Cohorts in Europe and the United States.

The Journal of nutrition·2026
See all related articles

Selecting appropriate metabolic and nutritional endpoints is crucial for managing wasting disorders. Using multiple endpoints and understanding potential errors ensures reliable data for effective intervention strategies.

Area of Science:

  • Metabolic research
  • Clinical trial design
  • Nutritional science

Background:

  • Current metabolic indicators are insufficient as single endpoints for managing wasting disorders.
  • Existing indicators may be more suitable for acute rather than chronic wasting conditions.
  • Multiple endpoints are necessary to ensure concordance and validity of findings.

Purpose of the Study:

  • To highlight the limitations of current metabolic indicators in wasting disorders.
  • To emphasize the need for careful selection and validation of endpoints in interventional studies.
  • To guide the development of appropriate strategies for interpreting data from wasting disorder interventions.

Main Methods:

  • Review of existing metabolic and nutritional indicators for wasting disorders.

Related Experiment Videos

  • Analysis of potential pitfalls and errors in endpoint measurement methodologies.
  • Discussion on the importance of experimental protocol design and focused research questions.

    • Main Results:

    • No single metabolic indicator is ideal for all wasting disorder interventions.
    • Acute and chronic wasting conditions may require different endpoint considerations.
    • Awareness of methodological limitations and data interpretation strategies is critical.

    Conclusions:

    • Multiple, validated endpoints are essential for reliable assessment of interventions in wasting disorders.
    • Endpoint selection must consider the specific disease, intervention effect, and study design.
    • Consensus among manufacturers, regulators, and investigators on endpoint selection is vital for advancing treatment.